Regeneration and Repair at Scale

BioDaVinci leverages a novel application of the most proven drug modality in history: small molecules.

Our AI platform maps bioelectric signaling (the software-like command layer of cells) to identify drugs that actively instruct regeneration and repair.

Through drug arbitrage, we identify safe chemistry that failed past clinical trials due to an indication mismatch.

Novel optimizations of this de-risked chemistry provides the foundation for BioDaVinci’s pipeline of first-in-class regenerative therapeutics